CARNITINE ADMINISTRATION PREVENTS THE PROGRESS OF ARTERIOSCLEROSIS BY REDUCING ADVANCED GLYCATION END PRODUCTS IN NON-DIABETIC MAINTENANCE HEMODIALYSISPATIENTS

被引:0
|
作者
Kamada, Yumi [1 ,2 ]
Masuda, Takashi [2 ]
Nakamura, Takeshi [2 ]
Yabu, Kanae [2 ]
Tanaka, Shinya [2 ]
Yamazaki, Joichi [2 ]
Hamazaki, Nobuaki [2 ]
Aoyama, Akihiro [2 ]
Itoh, Yoko [1 ]
Moriguchi, Ibuki [1 ]
Kobayashi, Naoyuki [1 ]
Okubo, Michihito [1 ]
Kotani, Kazuhiko [3 ]
Takeuchi, Kazuhiro [4 ]
Naito, Shokichi [4 ]
Takeuchi, Yasuo [4 ]
机构
[1] Sohbudai Nieren Clin, Dialysis, Zama, Japan
[2] Kitasato Univ, Grad Sch Med Sci, Dept Angiol & Cardiol, Sagamihara, Kanagawa 228, Japan
[3] Jichi Med Univ, Div Community & Family Med, Shimotsuke, Tochigi, Japan
[4] Kitasato Univ, Sch Med, Dept Internal Med, Div Nephrol, Sagamihara, Kanagawa 228, Japan
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MP413
引用
收藏
页码:1477 / 1477
页数:1
相关论文
共 50 条
  • [1] Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies
    Daroux, M.
    Prevost, G.
    Maillard-Lefebvre, H.
    Gaxatte, C.
    D'Agati, V. D.
    Schmidt, A. M.
    Boulanger, E.
    DIABETES & METABOLISM, 2010, 36 (01) : 1 - 10
  • [2] Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract
    Hashim, Zehra
    Zarina, Shamshad
    AGE, 2011, 33 (03) : 377 - 384
  • [3] Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract
    Zehra Hashim
    Shamshad Zarina
    AGE, 2011, 33 : 377 - 384
  • [4] Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications
    Gul, Anjuman
    Rahman, M. Ataur
    Salim, Asmat
    Simjee, Shabana U.
    AGE, 2008, 30 (04) : 303 - 309
  • [5] Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications
    Anjuman Gul
    M. Ataur Rahman
    Asmat Salim
    Shabana U. Simjee
    AGE, 2008, 30 : 303 - 309
  • [6] Increased physical activity prevents the progress of arteriosclerosis by reducing advanced glycation end products and oxidative stress in patients with diabetes mellitus, hypertension, and/or dyslipid
    Kamada, Y.
    Ito, S.
    Kamekawa, D.
    Katagiri, M.
    Ishii, H.
    Hotta, K.
    Yamamoto, S.
    Kamiya, K.
    Noda, C.
    Masuda, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 638 - 638
  • [7] Advanced glycation end products are associated with impaired vascular reactivity in non-diabetic subjects
    Matsuoka, H
    Murase, E
    Sugano, R
    CIRCULATION, 2001, 104 (17) : 370 - 370
  • [8] The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice
    Hansen, Laura M.
    Gupta, Divya
    Joseph, Giji
    Weiss, Daiana
    Taylor, W. Robert
    LABORATORY INVESTIGATION, 2017, 97 (01) : 34 - 42
  • [9] Recent progress in advanced glycation end products and diabetic complications
    Vlassara, H
    DIABETES, 1997, 46 : S19 - S25
  • [10] Advanced glycation end-products and cell adhesion molecules in chronic non-diabetic nephropathy
    Lecian, Dalibor
    Mareckova, Olga
    Teplan, Vladimir
    Bubenicek, Petr
    Kvasnicka, Jan
    Sebekova, Katerina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 127 - 127